The European Huntington’s Disease Network (EHDN) Plenary Meeting 2022 took place September 16-18 in Bologna, Italy.
As one of the world’s largest conferences dedicated to Huntington’s disease, EHDN 2022 boasted a packed scientific program covering important clinical news and basic research insights.
Our exclusive expert interviews explore the latest updates in the Huntington’s disease field!
AMT-130: the first gene therapy on the horizon for Huntington’s disease?
The first interim data has been published from a Phase I/II trial testing the safety and tolerability of AMT-130. If successful, this would be the first gene therapy for Huntington’s disease…